Gilead Sciences Inc (GILD)
89.80
+1.17
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
89.80
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Gross Profit Margin (Quarterly): 79.14% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 79.14% |
| June 30, 2024 | 77.79% |
| March 31, 2024 | 76.79% |
| December 31, 2023 | 70.62% |
| September 30, 2023 | 77.80% |
| June 30, 2023 | 78.15% |
| March 31, 2023 | 77.94% |
| December 31, 2022 | 81.11% |
| September 30, 2022 | 80.19% |
| June 30, 2022 | 76.96% |
| March 31, 2022 | 78.39% |
| December 31, 2021 | 63.74% |
| September 30, 2021 | 83.52% |
| June 30, 2021 | 77.64% |
| March 31, 2021 | 78.81% |
| December 31, 2020 | 81.16% |
| September 30, 2020 | 82.65% |
| June 30, 2020 | 79.31% |
| March 31, 2020 | 82.53% |
| December 31, 2019 | 71.37% |
| September 30, 2019 | 81.53% |
| June 30, 2019 | 82.41% |
| March 31, 2019 | 81.88% |
| December 31, 2018 | 72.91% |
| September 30, 2018 | 80.59% |
| Date | Value |
|---|---|
| June 30, 2018 | 78.82% |
| March 31, 2018 | 80.33% |
| December 31, 2017 | 78.89% |
| September 30, 2017 | 84.15% |
| June 30, 2017 | 84.23% |
| March 31, 2017 | 85.29% |
| December 31, 2016 | 85.31% |
| September 30, 2016 | 84.95% |
| June 30, 2016 | 88.89% |
| March 31, 2016 | 84.69% |
| December 31, 2015 | 87.51% |
| September 30, 2015 | 87.17% |
| June 30, 2015 | 87.89% |
| March 31, 2015 | 88.39% |
| December 31, 2014 | 85.47% |
| September 30, 2014 | 83.66% |
| June 30, 2014 | 85.85% |
| March 31, 2014 | 83.74% |
| December 31, 2013 | 72.50% |
| September 30, 2013 | 75.50% |
| June 30, 2013 | 75.26% |
| March 31, 2013 | 74.94% |
| December 31, 2012 | 73.90% |
| September 30, 2012 | 75.39% |
| June 30, 2012 | 74.33% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
63.74%
Minimum
Dec 2021
83.52%
Maximum
Sep 2021
77.78%
Average
78.27%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Merck & Co Inc | 75.51% |
| Pfizer Inc | 70.27% |
| Vertex Pharmaceuticals Inc | 85.84% |
| Amgen Inc | 61.07% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.64% |
| Return on Assets | 0.22% |
| Return on Invested Capital | 0.29% |
| Profit Margin (Quarterly) | 16.61% |
| Operating Margin (Quarterly) | 41.66% |
| Return on Net Operating Assets | 0.28% |